日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recommendations for medical student preparedness and equity for dermatology residency applications during the COVID-19 pandemic

针对新冠疫情期间医学生申请皮肤科住院医师培训的准备情况和公平性提出的建议

Stewart, Claire R; Chernoff, Karen A; Wildman, Horatio F; Lipner, Shari R

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial

贝利木单抗治疗早期弥漫性系统性硬化症:一项随机、双盲、安慰剂对照的试点试验结果

Gordon, Jessica K; Martyanov, Viktor; Franks, Jennifer M; Bernstein, Elana J; Szymonifka, Jackie; Magro, Cynthia; Wildman, Horatio F; Wood, Tammara A; Whitfield, Michael L; Spiera, Robert F

Endocrine mucin-producing sweat gland carcinoma of the scalp treated with Mohs micrographic surgery

采用莫氏显微外科手术治疗头皮内分泌黏液性汗腺癌

Navrazhina, Kristina; Petukhova, Tatyana; Wildman, Horatio F; Magro, Cynthia M; Minkis, Kira

Nicolau syndrome after lumbar puncture: A case report in a 22-month-old girl

腰椎穿刺后尼科劳综合征:一例22个月大女婴的病例报告

Navrazhina, Kristina; Cressey, Brienne D; Wildman, Horatio F

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

尼洛替尼(Tasigna™)治疗早期弥漫性系统性硬化症:一项开放标签的初步临床试验

Gordon, Jessica K; Martyanov, Viktor; Magro, Cynthia; Wildman, Horatio F; Wood, Tammara A; Huang, Wei-Ti; Crow, Mary K; Whitfield, Michael L; Spiera, Robert F

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

甲磺酸伊马替尼(格列卫)治疗弥漫性皮肤系统性硬化症:一项为期1年的IIa期单臂开放标签临床试验结果

Spiera, Robert F; Gordon, Jessica K; Mersten, Jamie N; Magro, Cynthia M; Mehta, Mansi; Wildman, Horatio F; Kloiber, Stacey; Kirou, Kyriakos A; Lyman, Stephen; Crow, Mary K